Peregrine Capital Management LLC Sells 7,571 Shares of Oak Street Health, Inc. (NYSE:OSH)

Peregrine Capital Management LLC lessened its stake in Oak Street Health, Inc. (NYSE:OSH – Get Rating) by 3.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 244,398 shares of the company’s stock after selling 7,571 shares during the period. Peregrine Capital Management LLC owned 0.10% of Oak Street Health worth $5,257,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Advisory Research Inc. bought a new stake in shares of Oak Street Health during the 3rd quarter valued at $201,000. Sandia Investment Management LP bought a new stake in shares of Oak Street Health during the 3rd quarter valued at $184,000. Alliancebernstein L.P. raised its position in shares of Oak Street Health by 74.0% during the 3rd quarter. Alliancebernstein L.P. now owns 81,615 shares of the company’s stock valued at $2,001,000 after acquiring an additional 34,713 shares during the last quarter. Public Employees Retirement System of Ohio raised its position in shares of Oak Street Health by 0.8% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 58,460 shares of the company’s stock valued at $1,433,000 after acquiring an additional 460 shares during the last quarter. Finally, Twinbeech Capital LP bought a new stake in shares of Oak Street Health during the 3rd quarter valued at $911,000. Institutional investors own 92.04% of the company’s stock.

Oak Street Health Stock Up 0.3 %

Shares of NYSE OSH opened at $35.64 on Friday. The company has a fifty day moving average price of $32.33 and a 200 day moving average price of $25.81. Oak Street Health, Inc. has a 1-year low of $13.29 and a 1-year high of $35.70.

Oak Street Health (NYSE:OSH – Get Rating) last posted its quarterly earnings data on Tuesday, February 28th. The company reported ($0.56) EPS for the quarter, topping analysts’ consensus estimates of ($0.58) by $0.02. Oak Street Health had a negative net margin of 23.57% and a negative return on equity of 1,883.59%. The company had revenue of $577.70 million during the quarter, compared to the consensus estimate of $571.26 million. During the same period in the prior year, the business posted ($0.62) EPS. The company’s quarterly revenue was up 46.6% on a year-over-year basis. As a group, sell-side analysts forecast that Oak Street Health, Inc. will post -1.58 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on OSH shares. Raymond James lowered shares of Oak Street Health from an “outperform” rating to a “market perform” rating in a report on Thursday, February 9th. Jefferies Financial Group lowered shares of Oak Street Health from a “buy” rating to a “hold” rating in a report on Thursday, February 9th. JPMorgan Chase & Co. lowered shares of Oak Street Health from an “overweight” rating to a “neutral” rating and boosted their price target for the company from $35.00 to $39.00 in a report on Thursday, February 23rd. William Blair lowered shares of Oak Street Health from an “outperform” rating to a “market perform” rating in a report on Thursday, February 9th. Finally, Piper Sandler lowered shares of Oak Street Health from an “overweight” rating to a “neutral” rating and decreased their price target for the company from $47.00 to $39.00 in a report on Wednesday, February 8th. One equities research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $33.27.

Insider Transactions at Oak Street Health

In other news, insider Geoffrey M. Price sold 50,000 shares of the stock in a transaction dated Tuesday, January 10th. The shares were sold at an average price of $29.74, for a total transaction of $1,487,000.00. Following the completion of the transaction, the insider now directly owns 3,824,863 shares in the company, valued at approximately $113,751,425.62. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other news, insider Geoffrey M. Price sold 50,000 shares of the company’s stock in a transaction dated Tuesday, January 10th. The shares were sold at an average price of $29.74, for a total value of $1,487,000.00. Following the sale, the insider now directly owns 3,824,863 shares of the company’s stock, valued at approximately $113,751,425.62. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Geoffrey M. Price sold 79,858 shares of the company’s stock in a transaction dated Thursday, March 16th. The shares were sold at an average price of $35.62, for a total transaction of $2,844,541.96. Following the completion of the sale, the insider now directly owns 3,874,769 shares in the company, valued at $138,019,271.78. The disclosure for this sale can be found here. Insiders sold a total of 763,105 shares of company stock worth $25,972,304 in the last three months. Insiders own 11.40% of the company’s stock.

Oak Street Health Profile

(Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.